Study on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma: Not a Case-Control Study.

dc.contributor.authorPuig i Sardà, Susana
dc.contributor.authorSampogna, Francesca
dc.contributor.authorTejera Vaquerizo, Antonio
dc.date.accessioned2017-05-03T17:32:43Z
dc.date.available2017-10-31T23:01:39Z
dc.date.issued2016-10
dc.date.updated2017-05-03T17:32:43Z
dc.description.abstractComentari a l'editor
dc.format.extent2 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec668018
dc.identifier.issn2168-6068
dc.identifier.pmid27732728
dc.identifier.urihttps://hdl.handle.net/2445/110405
dc.language.isoeng
dc.publisherAmerican Medical Association
dc.relation.ispartofJAMA Dermatology, 2016, vol. 152, num. 10, p. 1172-1173
dc.rights(c) American Medical Association, 2016
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationOncologia
dc.subject.classificationTumors
dc.subject.classificationMetabolisme basal
dc.subject.otherOncology
dc.subject.otherTumors
dc.subject.otherBasal metabolism
dc.titleStudy on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma: Not a Case-Control Study.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
668018.pdf
Mida:
68.48 KB
Format:
Adobe Portable Document Format